In5 was further analyzed for anticancer activity by testing the ability to induce Annexin V staining in three different cancer cell lines, i.e., the Jurkat T-cell line (T-cell leukemia), the Granta cell line (mantle cell lymphoma), and a melanoma cell line. This evidence concerns the gene ANXA5 and cancer.